Risk of Fixed Drug Eruption with Piroxicam (26 Sep 2022) On 26 Sep 2022, PvPI identified the Risk of Fixed Drug Eruption […]
Latest Articles
Read the latest release articles and learn without limits.
0
REMS Updates for September and October 2021
REMS Updates for September and October 2021 Here you can find REMS Updates for September and October 2021 REMS Updates for September […]
0
Update on Periodic Benefit-Risk Assessment Reports ANVISA_Brazil
Update on Periodic Benefit-Risk Assessment Reports ANVISA_Brazil_Updated on 24 August 2021 Background: In 2009, the first pharmacovigilance legislation at the national level […]
0
Update on Side effects of COVID-19 vaccines in Switzerland
Update on Side effects of COVID-19 vaccines in Switzerland As of 20 Apr 2021, Swissmedic has evaluated 1485 reports of suspected adverse […]
1
Adverse reaction reporting in New Zealand (2020)
Adverse reaction reporting in New Zealand (2020) On 22 April 2021, Med Safe published 2020-year Adverse reaction reporting statistics in New Zealand. […]
0
Increased risk of angioedema with vildagliptin and ACE inhibitors
Increased risk of angioedema with vildagliptin and ACE inhibitors In March 2021, Medsafe, the New Zealand Medicines and Medical Devices Safety Authority […]
0
Designated Medical Event (DME)
Designated Medical Event (DME) European Medicines Agency has developed the Designated Medical Event (DME) list to help to prioritize the review of […]
0
South African Health Products Regulatory Authority Launches the Med Safety App for Self Reporting
South African Health Products Regulatory Authority Launches the Med Safety App for Self Reporting On 22 Apr 2021, South African Health Products […]
0
Safety signal (risk of thrombosis in combination with thrombocytopenia) VAXZEVRIA/COVID-19 Vaccine
Safety signal (risk of thrombosis in combination with thrombocytopenia) VAXZEVRIA/COVID-19 Vaccine European Medicines Agency EMA) has published Direct healthcare professional communications (DHPC) […]
1
Remdesivir Safety Profile
Remdesivir Safety Profile Remdesivir authorized in the EU as Veklury Remdesivir is an antiviral medicine used to treat coronavirus disease 2019 (COVID-19). […]
